Cystathionine-β-synthase deficiency: Detection of heterozygotes by the ratios of homocysteine to cysteine and folate

Metabolism: Clinical and Experimental

Volumn 47, Issue 2, 1998, Pages 207-211

  Boddie, A M ^a   Steen, M T ^a   Sullivan, K M ^a   Pasquali, M ^a   Dembure, P P ^a   Coates, R J ^a   Elsas II, L J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; GENOTYPE; HETEROZYGOSITY; HOMOCYSTINURIA; HUMAN; HUMAN CELL; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TREATMENT PLANNING;

EID: 0031907640     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90222-0     Document Type: Article

References (27)

1. Brattstrom LB, Israelson B, Norrving B, et al: Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: Effects of pyridoxine and folic acid treatment. Atherosclerosis 81:51-60, 1990
2. Boushey CJ, Beresford SAA, Omenn GS, et al: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 27:1049-1057, 1995
3. Clarke R, Daly L, Robinson K, et al: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
4. Malinow MR, Stampfer MJ: Role of plasma homocyst(e)ine in arterial occlusive diseases. Clin Chem 40:857-858, 1994
5. Finkelstein JD: Methionine metabolism in mammals. J Nutr Biochem 1:228-237, 1990
6. Mudd SH, Levy HL, Skovby F: Disorders of transsulfuration, in Scriver CR, Beaudet AL, Sly WS, et al (eds): The Metabolic and Molecular Basis of Inherited Disease (ed 7). New York, NY, McGraw-Hill, 1995, pp 1279-1327
7. Griffin RF, Elsas LJ: Classic phenylketonuria: Diagnosis through heterozygote detection. J Pediatr 86:512-517, 1975
8. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987
9. Gardner MJ, Altman DG: Estimating with confidence. Clin Res 296:1210-1211, 1988 (editorial)
10. Hennekens CH, Burning JE: Screening, in Mayrent SL (ed): Epidemiology in Medicine. Boston, MA, Little, Brown, 1987, pp 327-347
11. Griffin RF, Humienny ME, Hall EC, et al: Classic phenylketonuria: Heterozygote detection during pregnancy. Am J Hum Genet 25:646-654, 1973
12. Paul TD, Brandt IK, Elsas LJ, et al: Linkage analysis using heterozygote detection in phenylketonuria. Clin Genet 16:217-232, 1979
13. Rozen R: Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clin Invest Med 19:171-178, 1996
14. Morrow G, Barness LA: Combined vitamin responstveness in homocystinuria. J Pediatr 81:946-954, 1972
15. Carey MC, Donovan DE, FitzGerald O, et al: Homocystinuria I, a clinical and pathological study of nine subjects in six families. Am J Med 45:7-25, 1968
16. Carey MC, Fennelly JJ, FitzGerald O: Homocystinuria II, subnormal serum folate levels, increased folate clearance and effects of folic acid therapy. Am J Med 45:26-31, 1968
17. Joosten E, Lesaffre R, Reizler R: Are different reference intervals for methylmalonic acid and total homocysteine necessary in elderly people? Eur J Haematol 57:222-226, 1996
18. Guttormsen AB, Ueland PM, Nesthus I, et al: Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/liter). The Hordaland Homocysteine Study. J Clin Invest 98:2174-2183, 1996
19. Jacques PF, Bostom AG, Williams RR, et al: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9, 1996
20. Kozich V, Kraus E, de Frranchis R, et al: Hyperhomocysteinemia in premature arterial disease: Examination of cystathionine β-synthase alleles at the molecular level. Hum Mol Genet 4:623-629, 1995
21. Hu FL, Gu Z, Kozich V, et al: Molecular basis of cystathionine β-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 2:1857-1860, 1993
22. Dawson PA, Cochran DAE, Emmerson BT, et al: Variable hyperhomocysteinaemia phenotype in heterozygotes for the Gly307Ser mutation in cystathionine β-synthase. Aust NZ J Med 26:180-205, 1996
23. Gallager PM, Ward P, Tan S, et al: High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients. Hum Mutat 6:177-180, 1995
24. Gallagher PM, Meleady R, Shields DC, et al: Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation 94:2154-2158, 1996
25. Ma J, Stampfer MJ, Hennekens CH, et al: Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94:2410-2416, 1996
26. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35-41, 1996
27. Graham IM, Daly LE, Refsum HM, et al: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775-1781, 1997